Antares Pharma, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Antares Pharma, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Antares Pharma, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Antares Pharma, Inc. including a breakdown and examination of key business segments
Intelligence on Antares Pharma, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Antares Pharma, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Antares Pharma (Antares or 'the company') is a specialty pharmaceutical company focusing on self-injection pharmaceutical products and technologies, and topical gel-based products. The company operates in the US, Europe and other regions of the world. It is headquartered in Ewing, New Jersey, and employed 93 people as on March 01, 2015. The company recorded revenues of $26.5 million during the financial year ended December 2014 (FY2014), an increase of 28.5% over FY2013. The operating loss of the company was $35.1 million in FY2014, as compared with an operating loss of $20.9 million in FY2013. The net loss of the company was $35.2 million in FY2014, as compared with a net loss of $20.5 million in FY2013.
Reasons to Purchase:
Gain understanding of Antares Pharma, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Antares Pharma, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Antares Pharma, Inc.’s business structure, strategy and prospects